|
시장보고서
상품코드
1347206
아메리카의 수면 무호흡증 시장 예측(-2030년) - 유형별, 최종사용자별 지역 분석Americas Sleep Apnea Market Forecast to 2030 - Regional Analysis By Type (Diagnostic Devices and Therapeutic Devices) and End User (Hospitals, Homecare Settings, and Others) |
||||||
아메리카 수면무호흡증 시장은 2022년 24억 5,420만 달러에서 2030년 41억 324만 달러로 성장할 것으로 예상되며, 2022년부터 2030년까지 6.6%의 CAGR을 기록할 것으로 예측됩니다. 수면무호흡증 유병률 증가, 수면무호흡증 진단 기기 및 치료 솔루션에 대한 수요 증가가 촉진요인으로 꼽힙니다. 그러나 수면무호흡증에 대한 낮은 인지도가 아메리카 지역의 수면무호흡증 시장 성장을 저해하는 요인으로 작용하고 있습니다.
아메리카 수면무호흡증 시장에서 활동하는 많은 시장 진입 기업 및 연구 기관은 제품 포트폴리오를 확장하고 시장 점유율을 확대하기 위해 첨단 제품을 개발하고 있습니다. 이들 기업은 첨단 제품을 개발하기 위해 많은 연구 개발 비용을 투자하고 있습니다. 수면무호흡증과 관련된 최근 개발 중 일부는 다음과 같습니다.
2021년 9월 Cadwell은 Easy III PSG 및 EEG 시스템용 E3 카트를 미국 시장에 출시 할 것이라고 발표했습니다. 선반과 수납공간을 갖춘 인체공학적 이동식 워크스테이션으로 설계됐습니다.
2021년 9월, 필립스는 재작업이 시작될 것으로 예상하고 있습니다. 재 작업 외에도 회사는 이미 미국에서 영향을받는 1 세대 드림 스테이션 CPAP 장비의 일부를 드림 스테이션 2 CPAP 장비로 교체하기 시작했습니다.
이러한 시장 개척은 예측 기간 동안 아메리카 수면무호흡증 시장에 새로운 트렌드를 가져올 가능성이 높습니다.
지속적인 기술 발전과 수면무호흡증에 대한 인식이 높아짐에 따라 PSG, 가정용 수면 검사 등 다양한 의료기기의 채택이 증가하고 있습니다. 많은 업계 진입자들이 수면무호흡증 진단 장비에 대한 수요 증가에 대응하기 위해 혁신적인 제품 전략에 집중하고 있습니다. 예를 들어, 2021년 8월 ResMed는 미국 최초로 'AirSense 11'을 출시했습니다. 2020년 8월, 일본광전공업은 수면무호흡증으로 고통받는 사람들을 돕기 위해 고안된 차세대 기도 양압기인 'Polysmith 12'를 출시했으며, Polysmith 소프트웨어에는 수면 전문의가 의료 장비의 워크플로우, 분석, 결과를 개선할 수 있는 40개 이상의 시장 선도적 기능을 포함하고 있습니다. 신제품은 또한 워크플로우를 강화하기 위한 스케줄링, 우선순위 지정, 이메일 알림 기능 강화, 우선순위와 상태에 따라 환자를 정리할 수 있는 향상된 상태 추적 기능, 임상 결과를 개선하기 위한 환자 진행 상황 추적 기능 등 다양한 기능을 갖춘 비용 효율적인 설계를 제공합니다. 2021년 9월, 수면 건강을 개선하는 제품 및 서비스 제조의 선구자인 소메트릭스는 OSA 치료를 위한 에어슬립 II(aerSleep II) 장치에 대한 매우 중요한 임상시험의 시작을 발표했습니다. 회사는 이 임상시험을 'SUPRA 시험'(즉, 수면무호흡증후군의 감소를 위한 음압을 이용한 시험)이라고 부르고 있습니다. 이 임상시험은 aerSleep II 장치를 이용해 상기도에 약한 외부 진공을 가함으로써 치료 효과와 안전성을 평가하는 것을 목적으로 합니다. 이처럼 혁신적인 제품 출시와 임상시험은 예측 기간 동안 시장 진입 기업들에게 유리한 기회를 제공할 것으로 예측됩니다.
유형별 인사이트
유형별로 살펴보면, 세계 아메리카 수면무호흡증 시장은 진단 장비와 치료 장비로 구분됩니다. 진단 장비는 다시 수면다원검사기(PSG), 가정용 수면 검사 장비, 맥박 산소 측정기, 액티그래프 장비, 기타로 세분화됩니다. 치료 장비는 PAP, 수면 마스크, 구강 기기, 기타로 세분화되며, 2022년 시장 점유율은 치료 분야가 가장 크고, 진단 장비는 예측 기간(2022-2030년) 동안 7.4%의 CAGR을 기록할 것으로 예상됩니다.
최종사용자 기반 인사이트
아메리카 수면무호흡증 시장은 최종사용자에 따라 병원, 홈케어 환경, 기타로 분류됩니다. 병원 부문은 2022년 시장에서 가장 큰 점유율을 차지할 것으로 예상되며, 홈케어 환경은 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다.
아메리카 수면무호흡증 시장에 대한 보고서를 작성할 때 참고한 주요 1차 및 2차 정보에는 세계보건기구(WHO), 미국 인구조사국, 미국 국립의학도서관 등이 포함됩니다.
목차
제1장 서론
제2장 아메리카의 수면무호흡증 시장 - 요점
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 아메리카의 수면무호흡증 시장 - 시장 상황
- 아메리카의 PEST 분석
제5장 수면무호흡증 시장 - 주요 시장 역학
- 시장 성장 촉진요인
- 수면무호흡증 유병률 증가
- 수면무호흡증 진단 기기와 치료 솔루션에 대한 수요 증가
- 시장 성장 억제요인
- 수면무호흡증의 낮은 인지도
- 시장 기회
- 혁신적인 제품 출시와 임상시험
- 향후 동향
- 기술 개발
- 영향 분석
제6장 아메리카의 수면무호흡증 시장 - 지역 분석
- 아메리카의 수면무호흡증 시장 매출 예측과 분석
제7장 아메리카의 수면무호흡증 시장, 2030년까지 매출과 예측 : 유형별
- 개요
- 아메리카의 수면무호흡증 시장, 2022년·2030년 : 유형별(%)
- 진단용 디바이스
- 치료 디바이스
제8장 아메리카의 수면무호흡증 시장 분석과 2028년까지 예측 : 최종사용자별
- 개요
- 아메리카의 수면무호흡증 시장, 2022년·2030년 : 최종사용자별(%)
- 병원
- 재택의료
- 기타
제9장 아메리카의 수면무호흡증 시장, 2030년까지 매출과 예측 : 지역 분석
제10장 COVID-19 전후의 영향
- COVID-19 전후의 영향
제11장 업계 상황
- 개요
- 유기적 전개
- 무기적 전개
제12장 기업 개요
- ResMed Inc
- Nihon Kohden Corp
- Fisher & Paykel Healthcare Ltd
- Koninklijke Philips NV
- Cadwell Industries Inc
- Natus Medical Inc
- Compumedics Limited
- LivaNova Plc
- Invacare Corp
- Braebon Medical Corporation
- Financial Overview
제13장 부록
ksm 23.10.25The Americas sleep apnea market is expected to grow from $ 2,454.20 million in 2022 and is expected to reach to a value of US$ 4,103.24 million by 2030, it is anticipated to record a CAGR of 6.6% from 2022 to 2030. The driving factors include increasing prevalence of sleep apnea and growing demand for sleep apnea diagnostic devices and therapeutic solutions. However, low awareness of sleep apnea is hampering the Americas sleep apnea market growth.
Many market players and research institutes operating in the Americas sleep apnea market are developing advanced products to expand their product portfolios and increase their market shares. They invest significant amounts in R&D to develop advanced products. A few of the recent developments related to sleep apnea are mentioned below:
In September 2021, Cadwell is proud to announce the release of the E3 cart for the Easy III PSG and EEG systems into the USA Market. The E3 Cart is designed to be an ergonomic, mobile workstation with optimal shelf and storage space for accessories commonly used in a sleep lab, such as CPAP equipment, Transcutaneous CO2 monitors and a EtCO2 monitors.
In September 2021, Philips anticipates rework to commence in the course of September 2021. In addition to the rework, the company has already started replacing certain affected first-generation DreamStation CPAP devices in the US with DreamStation 2 CPAP devices.
Thus, such development are likely to introduce new trends in the Americas sleep apnea market during the forecast period.
Constant technological advancements and awareness regarding sleep apnea are boosting the adoption of various medical devices, such as PSG and home sleep testing. Many industry players are focusing on innovative product strategies to meet the growing demand for sleep apnea diagnostic devices. For instance, in August 2021, ResMed successfully launched "AirSense 11," the first available in the US. It is the company's next-generation positive airway pressure device designed to assist people suffering from sleep apnea. In August 2020, Nihon Koden Corporation announced the launch of Polysmith 12 polysomnography software. The Polysmith software includes more than 40 market-driven features that offer sleep specialists to improve workflow, analysis, and outcomes of the medical device. The new product also offers a cost-effective design with a broad range of features, such as the enhancement of scheduling, prioritization, and email notification capabilities for enhanced workflow, improved status tracking to organize patients based on priority and status, and the ability to track patient progress to improve clinical outcomes. In September 2021, Sommetrics, a pioneer in manufacturing products and services to improve sleep health, announced the launch of a pivotal clinical trial for the "aerSleep II device" for the treatment of OSA. The company termed the clinical trial as "SUPRA study" (i.e., Study Using Negative Pressure to Reduce Sleep Apnea). The trial aims to evaluate the treatment benefits and safety of applying a mild external vacuum over the upper way airway with the aerSleep II device. Thus, such innovative product launches and clinical trials are projected to offer lucrative opportunities to the market players during the forecast period.
Type-Based Insights
Based on type, the global Americas sleep apnea market is segmented into diagnostic devices and therapeutic devices. Diagnostic devices is further sub-segmented as polysomnography devices (PSG), home sleep testing devices, pulse oximeters, actigraphy devices, and others. Therapeutic devices is further sub-segmented as PAP, sleep masks, oral appliances, and others. The therapeutics segment held the largest market share in 2022 and diagnostic devices is anticipated to register the highest CAGR of 7.4% during the forecast period (2022-2030).
End-User-Based Insights
Based on end-user, the Americas sleep apnea market, is segmented into hospitals, homecare settings, and others. The hospitals segment held the largest share of the market in 2022 and homecare settings is expected to grow at the highest CAGR during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the Americas sleep apnea market are the World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine, among others.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Americas sleep apnea market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global Americas sleep apnea market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Americas Sleep Apnea Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Americas Sleep Apnea Market - Market Landscape
- 4.1 Overview
- 4.1.1 Americas PEST Analysis
5. Sleep Apnea Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Sleep Apnea
- 5.1.2 Growing Demand for Sleep Apnea Diagnostic Devices and Therapeutic Solutions
- 5.2 Market Restraints
- 5.2.1 Low Awareness of Sleep Apnea
- 5.3 Market Opportunities
- 5.3.1 Innovative Product Launches and Clinical Trials
- 5.4 Future Trends
- 5.4.1 Technological Developments
- 5.5 Impact Analysis
6. Americas Sleep Apnea Market - Regional Analysis
- 6.1 Americas Sleep Apnea Market Revenue Forecast and Analysis
7. Americas Sleep Apnea Market - Revenue and Forecast to 2030 - by Type
- 7.1 Overview
- 7.2 Americas Sleep Apnea Market Revenue Share, by Type 2022 & 2030 (%)
- 7.3 Diagnostic Devices
- 7.3.1 Overview
- 7.3.2 Diagnostic Devices: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Polysomnography Devices (PSG)
- 7.3.3.1 Overview
- 7.3.3.2 Polysomnography Devices (PSG): Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 Home Sleep Testing Devices
- 7.3.4.1 Overview
- 7.3.4.2 Home Sleep Testing Devices: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Pulse Oximeters
- 7.3.5.1 Overview
- 7.3.5.2 Pulse Oximeters: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Actigraphy Devices
- 7.3.6.1 Overview
- 7.3.7 Actigraphy Devices: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.8 Others
- 7.3.8.1 Overview
- 7.3.9 Others: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Therapeutic Devices
- 7.4.1 Overview
- 7.4.2 Therapeutic Devices: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 PAP
- 7.4.3.1 Overview
- 7.4.3.2 PAP: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3.3 CPAP
- 7.4.3.3.1 Overview
- 7.4.3.3.2 CPAP: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3.4 APAP
- 7.4.3.4.1 Overview
- 7.4.3.4.2 APAP: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3.5 Bi-PAP
- 7.4.3.5.1 Overview
- 7.4.3.5.2 Bi-PAP: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Sleep Masks
- 7.4.4.1 Overview
- 7.4.4.2 Sleep Masks: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.5 Oral Appliances
- 7.4.5.1 Overview
- 7.4.5.2 Oral Appliances: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.6 Others
- 7.4.6.1 Overview
- 7.4.6.2 Others: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
8. Americas Sleep Apnea Market Analysis and Forecasts to 2028 - by End User
- 8.1 Overview
- 8.2 Americas Sleep Apnea Market, by End User 2022 & 2030 (%)
- 8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Homecare Settings
- 8.4.1 Overview
- 8.4.2 Homecare Settings: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
9. Americas Sleep Apnea Market - Revenue and Forecast to 2030 - Geographic Analysis
- 9.1 Americas Sleep Apnea Market, Revenue and Forecast to 2030
- 9.1.1 Overview
- 9.1.2 Americas Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.2.1 Americas Sleep Apnea Market, by Type
- 9.1.2.2 Americas Sleep Apnea Market, by Diagnostic Devices
- 9.1.2.3 Americas Sleep Apnea Market, by Therapeutic Devices
- 9.1.2.3.1 Americas Sleep Apnea Market, by PAP
- 9.1.2.4 Americas Sleep Apnea Market, by End User
- 9.1.2.5 Americas Sleep Apnea Market by Country
- 9.1.2.6 US
- 9.1.2.6.1 Overview
- 9.1.2.6.2 US Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.2.7 US Sleep Apnea Market, by Type
- 9.1.2.7.1 US Sleep Apnea Market, by Diagnostic Devices
- 9.1.2.7.2 US Sleep Apnea Market, by Therapeutic Devices
- 9.1.2.7.2.1 US Sleep Apnea Market, by PAP
- 9.1.2.8 US Sleep Apnea Market, by End User
- 9.1.2.9 Canada
- 9.1.2.9.1 Overview
- 9.1.2.9.2 Canada Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.2.10 Canada Sleep Apnea Market, by Type
- 9.1.2.10.1 Canada Sleep Apnea Market, by Diagnostic Devices
- 9.1.2.10.2 Canada Sleep Apnea Market, by Therapeutic Devices
- 9.1.2.10.2.1 Canada Sleep Apnea Market, by PAP
- 9.1.2.11 Canada Sleep Apnea Market, by End User
- 9.1.2.12 Mexico
- 9.1.2.12.1 Overview
- 9.1.2.12.2 Mexico Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.2.13 Mexico Sleep Apnea Market, by Type
- 9.1.2.13.1 Mexico Sleep Apnea Market, by Diagnostic Devices
- 9.1.2.13.2 Mexico Sleep Apnea Market, by Therapeutic Devices
- 9.1.2.13.2.1 Mexico Sleep Apnea Market, by PAP
- 9.1.2.14 Mexico Sleep Apnea Market, by End User
- 9.1.2.15 Brazil
- 9.1.2.15.1 Overview
- 9.1.2.15.2 Brazil Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.2.16 Brazil Sleep Apnea Market, by Type
- 9.1.2.16.1 Brazil Sleep Apnea Market, by Diagnostic Devices
- 9.1.2.16.2 Brazil Sleep Apnea Market, by Therapeutic Devices
- 9.1.2.16.2.1 Brazil Sleep Apnea Market, by PAP
- 9.1.2.17 Brazil Sleep Apnea Market, by End User
- 9.1.2.18 Argentina
- 9.1.2.18.1 Overview
- 9.1.2.18.2 Argentina Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.2.19 Argentina Sleep Apnea Market, by Type
- 9.1.2.19.1 Argentina Sleep Apnea Market, by Diagnostic Devices
- 9.1.2.19.2 Argentina Sleep Apnea Market, by Therapeutic Devices
- 9.1.2.19.2.1 Argentina Sleep Apnea Market, by PAP
- 9.1.2.20 Argentina Sleep Apnea Market, by End User
- 9.1.2.21 Chile
- 9.1.2.21.1 Overview
- 9.1.2.21.2 Chile Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.2.22 Chile Sleep Apnea Market, by Type
- 9.1.2.22.1 Chile Sleep Apnea Market, by Diagnostic Devices
- 9.1.2.22.2 Chile Sleep Apnea Market, by Therapeutic Devices
- 9.1.2.22.2.1 Chile Sleep Apnea Market, by PAP
- 9.1.2.23 Chile Sleep Apnea Market, by End User
- 9.1.2.24 Peru
- 9.1.2.24.1 Overview
- 9.1.2.24.2 Peru Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.2.25 Peru Sleep Apnea Market, by Type
- 9.1.2.25.1 Peru Sleep Apnea Market, by Diagnostic Devices
- 9.1.2.25.2 Peru Sleep Apnea Market, by Therapeutic Devices
- 9.1.2.25.2.1 Peru Sleep Apnea Market, by PAP
- 9.1.2.26 Peru Sleep Apnea Market, by End User
- 9.1.2.27 Colombia
- 9.1.2.27.1 Overview
- 9.1.2.27.2 Colombia Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.2.28 Colombia Sleep Apnea Market, by Type
- 9.1.2.28.1 Colombia Sleep Apnea Market, by Diagnostic Devices
- 9.1.2.28.2 Colombia Sleep Apnea Market, by Therapeutic Devices
- 9.1.2.28.2.1 Colombia Sleep Apnea Market, by PAP
- 9.1.2.29 Colombia Sleep Apnea Market, by End User
- 9.1.2.30 Rest of Americas
- 9.1.2.30.1 Overview
- 9.1.2.30.2 Rest of Americas Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.2.31 Rest of Americas Sleep Apnea Market, by Type
- 9.1.2.31.1 Rest of Americas Sleep Apnea Market, by Diagnostic Devices
- 9.1.2.31.2 Rest of Americas Sleep Apnea Market, by Therapeutic Devices
- 9.1.2.31.2.1 Rest of Americas Sleep Apnea Market, by PAP
- 9.1.2.32 Rest of Americas Sleep Apnea Market, by End User
10. Pre and Post COVID-19 Impact
- 10.1 Pre and Post COVID-19 Impact
11. Industry Landscape
- 11.1 Overview
- 11.2 Organic Developments
- 11.2.1 Overview
- 11.3 Inorganic Developments
- 11.3.1 Overview
12. Company Profiles
- 12.1 ResMed Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Nihon Kohden Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Fisher & Paykel Healthcare Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Koninklijke Philips NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Cadwell Industries Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Natus Medical Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Compumedics Limited
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 LivaNova Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Invacare Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Braebon Medical Corporation
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.11 Financial Overview
- 12.11.1 SWOT Analysis
- 12.11.2 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
